Antibiotics and Bacterial Resistance
Rationale
The World Economic Forum report claimed that ‘The world will run out of effective antibiotics.’ (Boseley, 2014) The article discussed broadly the link between the overuse of antibiotics and how it would cause antibiotic resistance and superbugs in hospitals, resulting in the death of lots of people. The report concluded that antibiotic-resistant bacteria are the greatest risk to human health, as the bacteria is growing stronger and acquiring resistance to multiple drugs. (Spellberg, Bartlett, & Gilbert, 2013)
Consequently, with initial research, a broad research question ‘Does the overuse of antibiotics lead to an antibiotic resistance?’ was developed based on the initial claim. This was further refined to specifically consider the emergence of superbugs in hospitals due to the overuse of antibiotics. A summary of this refinement and the specific research question is detailed below.
The use of antibiotics for human therapy is one of the most successful episodes in medicine. However, the consequences of overusing antibiotics are well-studied for human pathogens, which have evolved and acquired resistance along the past decades. (Nathan & Cars, 2014) It was stated that this evolution is of concern for the treatment of bacterial infections and for several medical practices that require the use of antibiotics to avoid the frequently associated infections. (Publications, 2013)
According to the Nature Research journal, novel antibiotics are always needed, owing to the inevitable development of resistance that follows the introduction of antibiotics to the clinic. it was also stated that when a new class of antibiotics is introduced, it is effective at first, but the bacteria will eventually develop resistance to the drug. (Walsh, 2003)
Therefore, this essay proposes the following research question:
‘Will the overuse of antibiotics in the treatment of bacterial infections lead to an antibiotic resistance and the emergence of Superbugs?’
Background
Antibiotics are bacteria-fighting drugs that have been an important part of modern medicine for nearly a century. (NIH , 2014) The effectiveness of antibiotics is measured on their ability to destroy or inhibit the growth of many harmful bacteria that cause infections, allowing for a longer and healthier life. Antibiotics work by attacking the parts that a bacterium needs to grow, survive and replicate. Each type of antibiotics acts in a different way; some antibiotics interfere with the outer casing of the bacteria, which is called a cell wall, while others may interfere with the mechanisms that allow the bacteria to reproduce. (Bennett & Luntz, 2006)
The overuse of antibiotics is a key factor leading to antibiotic resistance; making the once effective antibiotics, that are developed to treat infections, become increasingly ineffective. Consequently, the world is running out of effective antibiotics that are used to treat several serious diseases. Antibiotic resistance became an alarming subject in the last decades. (Bennett & Luntz, 2006) (Browne, 2013)
Antibiotic resistance occurs when the bacteria survive and reduce the effectiveness of antibiotics, making them completely ineffective by rapidly evolving to create ways of neutralising them, pumping them out of their cells, or preventing them from entering in the first place. (Cooper & Blaskovich, 2012) Bacteria have a capacity to replicate quickly, modify their genetic makeup and acquire new genes producing more resistant bacteria, which allow them to protect themselves from antibiotics. (Edwards-Jones, 2013) When bacteria become resistant to several types of antibiotics, they are often called ‘superbugs.’ Superbugs are strains of bacteria that are increasingly causing infections. The emerge of superbugs due to antibiotic resistance is a serious risk for global public health. (Browne, 2013)
Evidence
Antibiotics have helped to control and destroy many of the harmful bacteria. (NIH , 2014) However, the use of antibiotics is the single most important factor leading to antibiotic resistance and the emerge of superbugs worldwide. (Edwards-Jones, 2013) (Paper 28)
According to the Australian Commission on Safety and Quality in Health Care, the overuse of antibiotics in Australia is increasingly becoming a major public health problem and is considered the main cause of antibiotic resistance. (Manning, 2016) (AURA, 2016) The study stated that the more antibiotics are prescribed and used inappropriately, the more likely they will lose their effectiveness in the future, as the bacteria develops resistance more quickly. (McCaughey, 2016) (Oman Medical Journal, 2011) The graph below demonstrates the overuse of antibiotics in Australia.
Figure 1: Overall Antimicrobial Usage Rates by Jurisdiction, 2014
Source: (Australian Commission on Safety and Quality in Health Care, 2016)
Moreover, the studies indicated that antibiotics are used needlessly in residential aged care facilities. It indicated that 11.3% of the residents were on antimicrobials. However, only 4.5% had a suspected or confirmed infection. The study demonstrated the misuse of antibiotic in the Australian hospitals. On any given day in 2014, 38% of patients were being prescribed an antibiotic. However, 24.3% of these prescriptions were noncompliant with the guidelines and 23% were considered inappropriate. The inappropriate use of antibiotic included the over-prescribing of antibiotics needlessly, prescribing the wrong type of antibiotics, or prescribing for the incorrect duration. (AURA, 2016) Furthermore, According to the Centres for Disease Control and Prevention, up to one-third to one-half of antibiotic use in humans is unnecessary or inappropriate. (Mayo Clinic , 2018)
In 2014, 46% of Australians had at least one antimicrobial dispensed to them under the PBS or the RPBS. The overall rate was 23.8 DDD/1000 inhabitants/day, which is an increase compared with 2013, but a decrease compared with the peak in 2008, as shown in Figure 2. (AURA, 2016)
Figure 2: Volume of Antimicrobials Dispensed under the PBS/RPBS per year, 1994-2014
Source: (Australian Commission on Safety and Quality in Health Care, 2016)
According to the Centres for Disease Control and Prevention (CDC), Methicillin-resistant Staphylococcus aureus infections are among the highest of all antibiotic resistant threats. MRSA causes a range of illnesses, from skin and wound infections to pneumonia and bloodstream infections that can cause death. (CDC, 2013) It was also stated that resistance to methicillin, which is caused by the misuse of antibiotics, is of concern. (NIH , 2014)
Although MRSA infections in healthcare setting spear to be decreasing, it is still a common and severe threat. CDC estimates 80,461 invasive MRSA infections and 11,285 related deaths occurred in 2011. It also declared that a much higher number of less severe infections occurred in both the community and in healthcare settings. (CDC, 2013)
Figure 3: Revised Annualised National Estimates, Active Bacterial Core surveillance MRSA 2005-2011
Source: (Centres for Disease Control and Prevention, 2013)
Additionally, S. pneumoniae is a major health problem and is the leading cause of bacterial pneumonia and meningitis. It is also a major cause of bloodstream, ear and sinus infections. S. pneumoniae has developed resistance to drugs in the penicillin and erythromycin groups, such as amoxicillin, which are used in the treatment of several bacterial infections. According to CDC, Pneumococcal disease causes 4 million disease episodes and 22,000 deaths annually in the United States. (CDC, 2013)
Among children, Pneumococcal ear infections are the most common type of pneumococcal disease, causing 15 million infections. Moreover, over 600,000 adults are hospitalized with pneumococcal pneumonia. It was stated that, in 30% of severe S. pneumoniae cases, the bacteria are fully resistant to one or more clinically relevant antibiotics, which mostly results from the misuse of antibiotics, that are often prescribed needlessly. Invasive pneumococcal disease happens when the bacteria invade parts of the body that are usually sterile, causing death in most cases. The majority of deaths occur among those 65 years or older. (CDC, 2013)
Figure 4: Case of Antibiotic-Resistant Invasive Disease per 100,000 Persons, by Age Group and Resistance Profile _ Active Bacterial Core surveillance
Source: (Centres for Disease Control and Prevention, 2013)
Furthermore, TB is one of the most common infectious diseases and a huge cause of death worldwide. TB is caused by the bacteria Mycobacterium tuberculosis and is commonly spread through the air. It can affect any part of the body, but the bacteria is most found in the lungs. Drug-Resistant TB can be complex and challenging to treat. The major factors driving TB drug resistance are incomplete or wrong treatment, short drug supply, and the lack of new drugs. (CDC, 2013)
Figure 5: Reported Cases of Drug-Resistant TB (In thousands)
Source: (Columbia Threadneedle Investments, 2014)
According to CDC, In most cases, TB can be treatable with the available 1
st
line TB drugs. However, Multidrug-Resistant TB (MDR) can show resistance to at least Isoniazid (INH) and rifampicin (RMP), which are the essential 1
st
line drugs. (CDC, 2013) In some cases, TB is Extensively Drug-Resistant (XDR) which is resistant to almost all drugs used to treat TB. (WHO) As shown in the Figure 6, the collapse of the effective pharmaceutical antibacterial groups has led to a dramatic increase in the emergence of drug-resistant TB infections.
Figure 6: Cases of Antibiotic-Resistant TB by Age Group, 2011
Source: (Centres for Disease Control and Prevention, 2013)
The data from these studies demonstrated the serious issue of the overuse of antibiotic in Australia and the United States of America. The data appeared to be reliable and sufficient as it was taken over a long period of time and included a considerable number of patients. However, the results are limited as further data is required from across a larger sample of countries to provide more reliable and accurate patterns of antibiotic prescribing.
Evaluation
These studies were chosen in an attempt to ensure consistency of results about the connection between the overuse of antibiotics and Bacterial-resistance. The studies contained detailed information about antibiotic resistance and its serious effects, mostly caused from the misuse and the wrong prescriptions of antibiotics worldwide. The studies included some of the most common antibiotic-resistant diseases, such as MRSA, S. pneumoniae and TB, which are a huge cause of mortality worldwide.
The study of CDC in the United States and the study of AURA contained lots of information and trends about antibiotic-resistant infections. These studies demonstrated that the overuse of antibiotics definitely is one the of the major causes for the spread of bacterial-resistant diseases that are often untreatable. These studies were comprehensive and thoroughly explored the different variations of antibiotic resistance and resistant bacterial infections. However, there are issues associated with the evidence presented. The limitation of these studies was that they were especially focused on the over-prescribing and the patients in the United States and Australia, which limited the reliability and the accuracy of the data. The recommendation would be to include a larger sample of countries for more accurate and reliable results.
To truly investigate the accuracy of the claim, further testing would need to be carried out in several areas. This testing would need to include wider population of people with varieties of antibiotic-resistant diseases. For example, Improved diagnostic tests and promoted prescribing methods, such as shorter antibiotic courses and delayed prescriptions, would probably reduce the unnecessary prescribing to a large extent. Additionally, understanding the pharmacodynamics of antibiotic resistance is limited currently. A sharper focus on this area would help to determine optimum dosing schedules and durations of treatment. Moreover, the development of new vaccines and antibiotics that do not drive resistance would be essential. These strategies would minimise or prevent the worldwide problem of bacterial-resistant infections from occurring, to preserve the effectiveness of the available antibiotics.
Conclusion
On a balance of probabilities, the claim that ‘The world will run out of effective antibiotics’ appears to carry more weight. Although the studies and the data were more complete in some regions than the others, the evidence from the studies that have been addressed supported the claim and demonstrated that the overuse of antibiotics is leading to an antibiotic resistance and causing the emerge of superbugs. The studies discussed that the collapse of many effective antibiotics combined with the emergence of antibiotic-resistant bacteria has led to dramatic increases in the incidence and severity of bacterial infections.
Antibiotic resistance is a major threat to human health, and there is concern that in time there will be bacterial infections that cannot be treated. Resistance cannot be confronted without putting an end to the massive quantities of antibiotics that are exposed to the environment. Finally, novel approaches and effective therapies will always be needed to minimise this worldwide serious issue.
References
- AURA. (2016).
First Australian report on antimicrobial use and resistance in human health.
Retrieved from Antimicrobial Use and Resistance in Australia: https://www.safetyandquality.gov.au/sites/default/files/migrated/AURA-2016-Summary-Report.pdf - Bennett, C., & Luntz, S. (2006, June).
ANTIBIOTIC RESISTANCE: Emergence of the Superbugs.
Retrieved from ProQuest: https://search-proquest-com.ezproxy.slq.qld.gov.au/docview/220290524/fulltextPDF/66F1FE2B04D40C1PQ/1?accountid=13378 - Blaser, M. (2011, August 25).
Stop the killing of beneficial bacteria
. Retrieved from Natura Reserach: https://www.nature.com/articles/476393a - Boseley, S. (2014, April 30).
Antibiotics are losing effectiveness in every country, says WHO .
Retrieved from The Guardian: https://www.theguardian.com/society/2014/apr/30/antibiotics-losing-effectiveness-country-who - Browne, R. R. (2013, December).
Resistance to Antibiotics.
Retrieved from ProQuest: https://search-proquest-com.ezproxy.slq.qld.gov.au/docview/1462496507/abstract/4E038562FF46450FPQ/1?accountid=13378 - CDC. (2013).
Antibiotic Resistance Threats.
Retrieved from Centers for Disease Control and Prevention: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf - Cooper, M., & Blaskovich, M. (2012, October 29).
Explainer: what are antibiotics?
Retrieved from The Conversation: https://theconversation.com/explainer-what-are-antibiotics-9872 - Edwards-Jones, V. (2013, September 12).
Superbugs move faster than governments can act.
Retrieved from The Conversation: https://theconversation.com/superbugs-move-faster-than-governments-can-act-18160 - Howell L, e. (2013).
Global risks 2013, eighth edition: an initiative of the Risk Response Network.
Retrieved from World Economic Forum. - Mayo Clinic . (2018, January 18).
Antibiotics: Are you misusing them?
Retrieved from Mayo Clinic : https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/antibiotics/art-20045720 - McCaughey, L. C. (2016, June 10).
We know why bacteria become resistant to antibiotics, but how does this actually happen?
Retrieved from The Conversation: https://theconversation.com/we-know-why-bacteria-become-resistant-to-antibiotics-but-how-does-this-actually-happen-59891 - Nathan, C., & Cars, O. (2014, November 6).
Antibiotic Resistance — Problems, Progress, and Prospects.
Retrieved from The New England Joural of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMp1408040 - NIH . (2014, February ).
Stop the Spread of Superbugs
. Retrieved from News in Health: https://newsinhealth.nih.gov/2014/02/stop-spread-superbugs - Oman Medical Journal. (2011, September).
Treating Children Without Antibiotics in Primary Healthcare.
Retrieved from National Center for Biotechnology Information : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215439/ - Oman Medical Journal. (2011, September).
Treating Children Without Antibiotics in Primary Healthcare
. Retrieved from NCBI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215439/ - Publications, W. (2013, 2 5).
Antibiotics and Bacterial Resistance.
Retrieved from ProQuest: https://ebookcentral.proquest.com/lib/slq/reader.action?docID=1120859 - Spellberg, B., Bartlett, J. G., & Gilbert, D. N. (2013, January 24).
The Future of Antibiotics and Resistance
. Retrieved from The New England Journal of Medcine: https://www.nejm.org/doi/full/10.1056/NEJMp1215093 - Walsh, C. (2003, October 1).
Where will new antibiotics come from?
Retrieved from Nature Research: https://www.nature.com/articles/nrmicro727 - WHO. (n.d.).
Tuberculosis (TB) .
Retrieved from World Health Organization: https://www.who.int/tb/areas-of-work/drug-resistant-tb/xdr-tb-faq/en/ - Columbia Threadneedle Investments. (2014, May 14). Antibiotic Resistance – What It Means for Drug Manufacturers, Hospitals and Diagnostic Companies. Retrieved from: https://www.valuewalk.com/2014/05/antibiotic-resistance/
Australian Commission on Safety and Quality in Health Care. (2016).
First Australian report on antimicrobial use and resistance in human health. [Picture]. Retrieved from:
https://www.safetyandquality.gov.au/sites/default/files/migrated/AURA-2016-Summary-Report.pdf- Centers for Disease Control and Prevention. (2013).
Antibiotic Resistance Threats.[Picture].
Retrieved from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf
PLACE THIS ORDER OR A SIMILAR ORDER WITH NURSING TERM PAPERS TODAY AND GET AN AMAZING DISCOUNT
